Shaanxi Meibang Pharmaceutical Group Co., Ltd.
SSE:605033.SS
16.97 (CNY) • At close May 6, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2025 Q1 | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 289.412 | 262.748 | 113.175 | 195.979 | 312.087 | 145.391 | 77.487 | 131.44 | 344.708 | 222.023 | 66.376 | 130.09 | 487.556 | 292.054 | 74.256 | 201.601 | 274.58 | 155.118 | 47.991 | 147.588 | 217.821 |
| Cost of Revenue
| 192.187 | 201.472 | 76.271 | 145.155 | 212.894 | 105.365 | 58.385 | 86.734 | 209.444 | 128.189 | 37.769 | 74.32 | 278.578 | 165.777 | 45.626 | 132.181 | 176.478 | 103.571 | 29.424 | 92.186 | 136.682 |
| Gross Profit
| 97.225 | 61.276 | 36.903 | 50.824 | 99.194 | 40.026 | 19.102 | 44.706 | 135.265 | 93.835 | 28.608 | 55.77 | 208.978 | 126.276 | 28.63 | 69.42 | 98.101 | 51.547 | 18.567 | 55.402 | 81.139 |
| Gross Profit Ratio
| 0.336 | 0.233 | 0.326 | 0.259 | 0.318 | 0.275 | 0.247 | 0.34 | 0.392 | 0.423 | 0.431 | 0.429 | 0.429 | 0.432 | 0.386 | 0.344 | 0.357 | 0.332 | 0.387 | 0.375 | 0.373 |
| Reseach & Development Expenses
| 20.454 | 22.879 | 16.414 | 17.6 | 17.031 | 25.153 | 4.287 | 9.165 | 19.926 | 28.009 | 14.191 | 12.181 | 25.662 | 23.638 | 11.743 | 15.253 | 13.173 | 15.163 | 13.921 | 12.019 | 10.261 |
| General & Administrative Expenses
| 8.588 | -15.527 | 23.629 | -4.509 | 8.386 | -14.154 | 19.792 | -5.457 | 8.451 | -18.573 | 24.472 | -6.833 | 8.858 | -2.585 | 11.308 | 1.408 | 1.459 | -6.849 | 4.062 | 4.31 | 3.298 |
| Selling & Marketing Expenses
| 31.912 | -16.735 | 43.537 | 23.088 | 23.876 | 28.044 | 16.937 | 18.485 | 21.957 | 38.321 | 20.731 | 15.339 | 48.256 | 34.108 | 21.951 | 16.403 | 15.805 | 11.952 | 16.226 | 9.205 | 8.505 |
| SG&A
| 40.5 | -32.263 | 19.995 | 35.846 | 32.262 | 13.89 | 36.73 | 13.029 | 30.408 | 19.748 | 45.204 | 8.506 | 57.114 | 31.522 | 33.259 | 17.81 | 17.264 | 5.103 | 20.288 | 13.514 | 11.803 |
| Other Expenses
| 6.292 | 88.891 | -0.653 | -4.155 | 0.023 | 10.031 | 0.422 | 0.914 | 0.882 | 23.656 | -12.112 | 13.203 | 1.307 | 15.806 | 0.09 | 0.199 | 0.233 | 0.595 | 0.209 | 0.396 | 0.593 |
| Operating Expenses
| 67.247 | 79.508 | 36.543 | 57.601 | 44.183 | 63.312 | 29.133 | 35.5 | 51.216 | 71.413 | 47.283 | 33.89 | 84.083 | 72.842 | 39.499 | 36.944 | 34.121 | 31.586 | 34.683 | 26.181 | 22.654 |
| Operating Income
| 29.978 | -18.231 | 0.36 | -6.777 | 49.551 | -33.881 | -2.772 | 7.75 | 79.271 | 24.736 | -18.676 | 19.192 | 106.983 | 47.193 | -4.788 | 25.374 | 54.725 | 25.511 | -11.613 | 23.438 | 50.258 |
| Operating Income Ratio
| 0.104 | -0.069 | 0.003 | -0.035 | 0.159 | -0.233 | -0.036 | 0.059 | 0.23 | 0.111 | -0.281 | 0.148 | 0.219 | 0.162 | -0.064 | 0.126 | 0.199 | 0.164 | -0.242 | 0.159 | 0.231 |
| Total Other Income Expenses Net
| 1.134 | 4.834 | 0.714 | 7.384 | 0.023 | 10.031 | 0.422 | 0.914 | 0.675 | 1.092 | 1.207 | 9.843 | -0.048 | 15.806 | 0.09 | 0.199 | 0.233 | 0.595 | 0.209 | 0.396 | 0.593 |
| Income Before Tax
| 31.113 | -13.397 | 1.075 | 0.607 | 49.574 | -23.85 | -2.35 | 8.664 | 79.946 | 25.828 | -9.43 | 29.035 | 106.934 | 62.998 | -4.698 | 25.573 | 54.958 | 26.105 | -11.404 | 23.834 | 50.851 |
| Income Before Tax Ratio
| 0.108 | -0.051 | 0.009 | 0.003 | 0.159 | -0.164 | -0.03 | 0.066 | 0.232 | 0.116 | -0.142 | 0.223 | 0.219 | 0.216 | -0.063 | 0.127 | 0.2 | 0.168 | -0.238 | 0.161 | 0.233 |
| Income Tax Expense
| 1.16 | -6.98 | 5.226 | -2.383 | 5.136 | -11.216 | 1.07 | 4.329 | 10.67 | -7.485 | -4.23 | 3.812 | 15.182 | 0.985 | 1.013 | 2.709 | 8.381 | -1.332 | 1.062 | 3.269 | 7.652 |
| Net Income
| 29.952 | -6.417 | -4.152 | 2.99 | 44.438 | -12.634 | -3.42 | 4.335 | 69.276 | 33.313 | -5.2 | 25.223 | 91.752 | 62.013 | -5.711 | 22.864 | 46.576 | 27.438 | -12.467 | 20.565 | 43.198 |
| Net Income Ratio
| 0.103 | -0.024 | -0.037 | 0.015 | 0.142 | -0.087 | -0.044 | 0.033 | 0.201 | 0.15 | -0.078 | 0.194 | 0.188 | 0.212 | -0.077 | 0.113 | 0.17 | 0.177 | -0.26 | 0.139 | 0.198 |
| EPS
| 0.22 | -0.047 | -0.031 | 0.022 | 0.33 | -0.096 | -0.025 | 0.032 | 0.51 | 0.25 | -0.039 | 0.19 | 0.68 | 0.46 | -0.058 | 0.23 | 0.46 | 0.27 | -0.13 | 0.2 | 0.43 |
| EPS Diluted
| 0.22 | -0.047 | -0.031 | 0.022 | 0.33 | -0.096 | -0.025 | 0.032 | 0.51 | 0.25 | -0.039 | 0.19 | 0.68 | 0.46 | -0.056 | 0.23 | 0.46 | 0.27 | -0.12 | 0.2 | 0.41 |
| EBITDA
| 35.568 | -13.397 | 1.075 | 6.132 | 55.107 | -18.218 | 3.281 | 14.006 | 84.933 | 30.358 | -4.727 | 32.807 | 110.728 | 64.248 | -3.125 | 28.908 | 55.636 | 26.105 | -11.613 | 36.494 | 51.736 |
| EBITDA Ratio
| 0.123 | -0.051 | 0.009 | 0.031 | 0.177 | -0.125 | 0.042 | 0.107 | 0.246 | 0.137 | -0.071 | 0.252 | 0.227 | 0.22 | -0.042 | 0.143 | 0.203 | 0.168 | -0.242 | 0.247 | 0.238 |